Skip to content

Empirical treatment of Helicobacter pylori infection and its influencing factors: a single-center cohort study

Empirical treatment of Helicobacter pylori infection and its influencing factors: a single-center cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126271
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Observation group [According to empirical medication regimen, divided into 5 groups (CA-BQT, DA-BQT, FA-BQT, NA-BQT, HDDT)]:None

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. pre-treatment confirmation of H. pylori infection by 13C-UBT (DOB >= 4‰); 2. age >= 18 years; 3. completion of a standardized 14-day eradication regimen; 4. post-treatment 13C-UBT reassessment performed at our center 4–24 weeks after completion of therapy, with eradication success defined as DOB < 4‰.

Exclusion criteria

Exclusion criteria: 1. Competitive acid blockers (P-CABs) within the preceding month; 2. Severe cardiac, hepatic, or renal dysfunction; 3. Psychiatric disorders or cognitive impairment precluding adherence; 4. Follow-up 13C-UBT performed outside the prespecified 4–24-week window.

Design outcomes

Primary

MeasureTime frame
H. pylori eradication rate;

Secondary

MeasureTime frame
Eradication rate by stratified regimens;

Countries

China

Contacts

Public ContactLi Li

The Affiliated Hospital of Xuzhou Medical University

lily9711214@126.com+86 516 8580 6238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026